Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06272370 · ClinicalTrials.gov registry record · Phase 4
Individualizing Treatment for Asthma in Primary Care
A Phase 4 study, sponsored by DARTNet Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 103
- Enrollment target
NCT06272370 is a Phase 4 study that has completed, run by DARTNet Institute. The registered enrollment target is 103 participants.
The verdict
NCT06272370, a Phase 4 study, has completed, sponsored by DARTNet Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 103 participants
- Enrollment target
Study Summary
This is a patient level randomized trial for teenagers and adults with asthma who will be randomized to four arms - enhance usual care, rescue inhaled corticosteroids, azithromycin and both rescue inhaled corticosteroids and azithromycin. Participants in all arms will be offered access to an online asthma symptom monitoring system.
Interventions
- DRUG Azithromycin Pill
- OTHER Asthma Symptom Monitoring online tools
- DRUG Inhaled Steroids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06272370
The ClinicalTrials.gov registry entry for NCT06272370 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DARTNet Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Azithromycin Pill is the first listed.
NCT06272370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06272370 about?
NCT06272370 is a clinical study titled "Individualizing Treatment for Asthma in Primary Care". This is a patient level randomized trial for teenagers and adults with asthma who will be randomized to four arms - enhance usual care, rescue inhaled corticosteroids, azithromycin and both rescue inhaled corticosteroids and azithromycin. Participants in all arms will be offered access to an online ...
What is the current status of trial NCT06272370?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 103 participants. The study started on 2024-02-01. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06272370?
The interventions under investigation include: Azithromycin Pill (DRUG), Asthma Symptom Monitoring online tools (OTHER), Inhaled Steroids (DRUG).
Who is sponsoring clinical trial NCT06272370?
This trial is sponsored by DARTNet Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.